![Mahalakshmi Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahalakshmi Radhakrishnan
Director/Board Member at
ENTRADA THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Mahalakshmi Radhakrishnan occupies the position of Chief Medical Officer & Group Senior VP at Biogen, Inc. Dr. Radhakrishnan is also Senior Vice President & Head-Worldwide Medical at Bioverativ Therapeutics, Inc. In her past career Dr. Radhakrishnan held the position of Vice President for Biogen, Inc., Global Head-Medical & Primary Care Business Unit at Sanofi and Executive Director & Head-Therapeutic Area at Bristol-Myers Squibb Holdings Pharma LLC. Mahalakshmi Radhakrishnan received a doctorate from Peoples' Friendship University of Russia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-05-30 |
Mahalakshmi Radhakrishnan active positions
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director/Board Member | 2025-05-31 |
| CANDEL THERAPEUTICS, INC. | Director/Board Member | 2025-06-03 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Director/Board Member | 2022-11-28 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Director/Board Member | 2023-01-04 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 2024-07-31 |
Former positions of Mahalakshmi Radhakrishnan
| Companies | Position | End |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Director/Board Member | 2025-05-12 |
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 2024-02-29 |
| SANOFI | Corporate Officer/Principal | 2018-12-31 |
| BIOASIS TECHNOLOGIES INC. | Director/Board Member | 2018-07-26 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Mahalakshmi Radhakrishnan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Peoples' Friendship University of Russia
 Peoples' Friendship University of Russia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
- Stock Market
- Insiders
- Mahalakshmi Radhakrishnan
